Rigvir® for Breast Cancer: Overview, Mode of Action, and Application Process
One of the recipes to fight breast cancer is to approach virotherapy, which is mainly based on an oncolytic nonpathogenic virus ECHO-7. The drug was discovered in 1950-60s in Riga, Latvia and therefore became known as Rigvir®, short from Riga virus.
Breast cancer is one of the areas where Rigvir has demonstrated its efficacy
Since its invention, numerous clinical tests have been conducted showing that Rigvir® is able to destroy certain cancer cells. Melanoma patients were the first ones to benefit from the treatment. On top of that, over the years research on Rigvir® effectiveness has also demonstrated its capacity to fight:
- Bladder cancer
- Kidney cancer
- Colorectal cancer
- Ovarian cancer
- Breast cancer
- Uterine cancer
- Pancreatic cancer
- Prostate cancer
- Sarcomas (leiomyosarcoma, reticulosarcoma, lymphosarcoma, rhabdomyosarcoma, and angiosarcoma)
- Neuroendocrine tumors
Rigvir® is stored in vials in cold environments. After the drug gets injected into the muscle, it then quickly identifies cancer cells, penetrates into them, and destroys them from the inside. Unlike other types of treatment, virotherapy doesn’t affect healthy cells that surround the tumor. A slight increase in body temperature lasting up to 3 days has been registered as the only side effect of Rigvir® so far.
Virotherapy for Breast Cancer: Application Process
Remember that your case of breast cancer has to be studied individually. You can receive a personalized plan for Rigvir® treatment after oncologists from Global Virotherapy Cancer Clinic carry out free case evaluation.
Normally, the evaluation process of breast cancer cases takes up to three business days after which the patient coordinator informs you whether you qualify for Rigvir® therapy and provides further step-by-step instructions. You can find out more about Rigvir in the USA or Rigvir in Canada.
To perform the assessment of your health condition they will request the following medical documents:
- Recent full blood count (maximum standing of 2 weeks) with White Blood Cells (WBC) indicated
- Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) – some radiological documents
- Histopathological and cytological records
- Biochemical analyses for creatinine, alanine transferase (ALT).
If you would like to find out whether you or the one your love qualifies for Rigvir® therapy, click the button below and we’ll get back to you within 24 hours (usually sooner).